)
Sanara MedTech (SMTI) investor relations material
Sanara MedTech Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net revenue for Q3 2025 increased 22% year-over-year to $26.3 million, driven by strong sales of soft tissue repair products, especially CellerateRX Surgical and BiOSurge, and expansion into new healthcare facilities and distribution networks.
Discontinued the THP segment after a strategic review due to persistent losses and lack of investor interest, resulting in a $26.5 million noncash asset impairment charge and reclassification as discontinued operations.
Net income from continuing operations was $0.8 million in Q3 2025, reversing a net loss of $0.2 million in Q3 2024; Adjusted EBITDA rose to $4.9 million from $2.6 million.
Expanded distributor network to over 400 and increased healthcare facility customers to more than 1,400, with significant runway for further penetration.
Leadership transition with Seth Yon appointed President and CEO, succeeding Ron Nixon.
Financial highlights
Q3 2025 gross profit was $24.5 million, up 24% year-over-year, with gross margin improving to 93%.
Operating income for Q3 2025 was $2.9 million, a 278% increase year-over-year.
Adjusted EBITDA for Q3 2025 was $4.9 million, up from $2.6 million in Q3 2024; for the first nine months, Adjusted EBITDA was $12.3 million, up from $5.1 million.
Net cash provided by operating activities in Q3 2025 was $2.2 million; for the first nine months, $2.8 million.
Trailing 12-month net revenue reached nearly $102 million, up 31% year-over-year.
Outlook and guidance
Management expects continued strong, sustainable revenue growth and improved profitability for the remainder of 2025 and beyond, focusing on operational efficiency and investment in the surgical business.
Sufficient liquidity is expected for at least the next 12 months, with $14.9 million cash on hand and $12.25 million available under the CRG Term Loan as of September 30, 2025.
No material cash spend anticipated for THP after 2025; focus remains on profitable growth and operating leverage.
Next Sanara MedTech earnings date
Next Sanara MedTech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)